Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Healthtrust
QuintilesIMS
Medtronic
Dow
Colorcon
Cantor Fitzgerald
Covington

Generated: December 11, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TRAVATAN Z

« Back to Dashboard

Clinical Trials for Travatan Z

Trial ID Title Status Sponsor Phase Summary
NCT00047554 Study of TRAVATAN in Subjects With Iris Pigmentation Changes Terminated Alcon Research Phase 4 The purpose of this study was to monitor iris pigmentation changes over a 5-year period in patients with open-angle glaucoma or ocular hypertension. To be eligible for the study, these individuals must have experienced an iris pigmentation change while previously dosing with TRAVATAN.
NCT00051155 A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT) Completed Alcon Research Phase 3 To compare the safety and IOP-lowering efficacy of TRAVATAN and XALCOM in subjects with open-angle glaucoma or ocular hypertension.
NCT00051168 A Long-term Safety Study of Once-daily Travatan Completed Alcon Research Phase 3 Long term safety study of TRAVATAN in patients with Open-angle glaucoma or ocular hypertension.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Travatan Z

Condition Name

Condition Name for Travatan Z
Intervention Trials
Ocular Hypertension 38
Open-angle Glaucoma 19
Glaucoma 18
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Travatan Z
Intervention Trials
Glaucoma 45
Ocular Hypertension 40
Hypertension 32
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Travatan Z

Trials by Country

Trials by Country for Travatan Z
Location Trials
United States 60
Canada 4
Switzerland 1
Belgium 1
Portugal 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Travatan Z
Location Trials
Texas 9
California 4
New York 3
Massachusetts 3
Illinois 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Travatan Z

Clinical Trial Phase

Clinical Trial Phase for Travatan Z
Clinical Trial Phase Trials
Phase 4 29
Phase 3 10
Phase 2 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Travatan Z
Clinical Trial Phase Trials
Completed 40
Terminated 5
Unknown status 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Travatan Z

Sponsor Name

Sponsor Name for Travatan Z
Sponsor Trials
Alcon Research 37
Allergan 4
Pfizer 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Travatan Z
Sponsor Trials
Industry 46
Other 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Accenture
Daiichi Sankyo
Boehringer Ingelheim
McKinsey
Harvard Business School
Healthtrust
Medtronic
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.